In this study, we used FFA-induced nonalcoholic fatty liver cells as a model and investigated whether fucoxanthin regulated AMPK, Nrf2, and TLR4 pathways in FFA-induced NAFLD. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.